The U.S. Food and Drug Administration has approved a kit that will allow women to collect their own vaginal sample for HPV ...
"HPV self-collection offers an accessible screening option" and "will improve access to testing by providing women the option ...
The Food and Drug Administration this week moved to expand screening for potentially lethal cervical cancer by allowing women to collect test samples themselves, a move that reproductive health ...
The Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease for which an mRNA vaccine has been ...
HPV testing to prevent cervical cancer might not have to happen as often as currently recommended, a new study says. Current ...
Credit: Moderna. The approval was based on data from the phase 3 ConquerRSV trial, which included approximately 37,000 adults 60 years of age and older. The Food and Drug Administration (FDA) has ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved the first-ever mRNA-1345 vaccine (mRESVIA ...
, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product. Moderna's vaccine was approved for ...
Allowing pharmacists to treat minor illnesses could potentially expand healthcare access to more people and save millions of ...
FDA approves self-test for HPV UW Health's Dr. Jeff Pothof joined FOX6 to discuss FDA approval of the first self-test for HPV, as well as the calories needed to carry a fetus. Posted May 21, 2024 ...
The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name of ...
Moderna had filed for FDA approval in July on data from a late-stage trial that showed its vaccine was 84% effective at preventing those symptoms, and its shares were down more than 6% in ...